Antiviral activity of human β-defensin 3 against vaccinia virus
- 30 April 2007
- journal article
- other
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 119 (4), 1022-1025
- https://doi.org/10.1016/j.jaci.2007.01.044
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Mechanism of HBD-3 deficiency in atopic dermatitisClinical Immunology, 2006
- Innate immune defects in atopic dermatitisJournal of Allergy and Clinical Immunology, 2006
- Cytokines and chemokines orchestrate atopic skin inflammationJournal of Allergy and Clinical Immunology, 2006
- Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus ReportJournal of Allergy and Clinical Immunology, 2006
- Cathelicidin deficiency predisposes to eczema herpeticumJournal of Allergy and Clinical Immunology, 2006
- Cytokine Milieu of Atopic Dermatitis Skin Subverts the Innate Immune Response to Vaccinia VirusImmunity, 2006
- 10. Atopic dermatitisJournal of Allergy and Clinical Immunology, 2006
- Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic DermatitisJournal of Investigative Dermatology, 2005
- Selective Killing of Vaccinia Virus by LL-37: Implications for Eczema VaccinatumThe Journal of Immunology, 2004